Background: High serum phosphorus concentrations are associated with an increased risk of cardiovascular disease and progression of chronic kidney disease (CKD). However, the relation between dietary phosphorus intake and CKD development has not been well evaluated. Objective: In this study, we investigated the impact of dietary phosphorus density on the development of incident CKD in a cohort of subjects with normal renal function. Design: Data were retrieved from the Korean Genome and Epidemiology Study, a prospective community-based cohort study. The study cohort consisted of subjects aged 40-69 y, who were followed up biennially from 2001 to 2014. A total of 873 subjects with diabetes mellitus (DM) and 5846 subjects without DM (non-DM) were included in the final analysis. The primary endpoint was incident CKD, defined as a composite of estimated glomerular filtration rate ,60 mL $ min 21 $ 1.73 m 22 and/or the development of proteinuria. Results: In the DM and non-DM groups, the mean ages of the participants were 55.6 6 8.7 and 51.4 6 8.6 y, the numbers of male subjects were 454 (52.0%) and 2784 (47.6%), and the mean estimated glomerular filtration rates were 91.6 6 14.0 and 94.5 6 14.0 mL $ min 21 $ 1.73 m 22 , respectively. The mean values of dietary phosphorus density, defined as the ratio of a single-day dietary phosphorus amount to the total daily calorie intake, were 0.51 6 0.08 mg/kcal in the DM group and 0.51 6 0.07 mg/kcal in the non-DM group. During the follow-up, CKD newly developed in 283 (32.4%) and 792 subjects (13.5%) in the DM and non-DM groups, respectively. When the subjects were divided into quartiles according to the dietary phosphorus density in each group, the highest quartile was significantly associated with the development of incident CKD by multiple Cox proportional hazard analysis in the DM group (P = 0.02) but not in the non-DM group (P = 0.72). Conclusions: High dietary phosphorus density is associated with an increased risk of CKD development in DM patients with normal renal function. The causality in this association needs to be tested in a randomized controlled trial.
INTRODUCTION
The incidence and prevalence of chronic kidney disease (CKD), a major risk factor for morbidity and mortality in both those who have diabetes mellitus (DM) and those who do not (non-DM), are increasing rapidly (1, 2) . Considering the relentless decline in renal function in CKD patients, identifying modifiable risk factors and taking proper preventive actions are crucial for reducing the burden of CKD.
Phosphorus is a mineral element that plays important roles in a number of biological processes, including cell signaling and energy metabolism. Previous studies have demonstrated that high serum phosphate concentrations are significantly linked with the risk of cardiovascular disease and death in the general population as well as in people with CKD (3, 4) . Similar findings were also found in patients with end-stage renal disease and myocardial infarction (5) . Taken together, these findings suggest the possibility that the prevention and treatment of hyperphosphatemia can be beneficial for improving cardiovascular outcomes in some populations (3) . In addition to these reports showing a close relation between hyperphosphatemia and adverse cardiovascular outcomes, several investigations have also demonstrated that high serum phosphate concentrations are associated with a rapid decline in renal function in CKD patients, suggesting that excess circulating phosphorus may impair kidney function as well as cardiovascular health (6, 7) .
The serum phosphate concentration is regulated by the balance of dietary phosphorus absorption, renal excretion and reabsorption, and exchanges from bone and soft tissues (8) . Many previous studies have evaluated the impact of dietary phosphorus load on the clinical outcomes and found that dietary phosphorus intake is closely related to cardiovascular outcomes and death not only in the general population but also in patients with CKD (9) (10) (11) . However, the influence of dietary phosphorus load on renal outcomes has not yet been well explored.
In this study, we aimed to elucidate the association between dietary phosphorus density and the development of incident CKD in a prospective community-based cohort comprising subjects with normal renal function.
METHODS

Study population
All individuals participated in the present study voluntarily, and informed consent was obtained in all cases. This study was carried out in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Yonsei University Health System Clinical Trial Center (4-2016-0100).
The present study was performed by using data from the KoGES (Korean Genome and Epidemiology Study). The KoGES is an ongoing, prospective, community-based cohort study that began in June 2001. The detailed cohort profile of the KoGES has been described previously (12) . Briefly, the study cohort consisted of 10,030 participants, 40-to 69-y-old residents from the cities of Ansan and Ansung. Ansan consists of an urban community, whereas Ansung is a rural community. Both areas are located near Seoul, the capital of Republic of Korea. The subjects underwent health examinations and a number of surveys at baseline. Follow-up assessments for biochemical data were performed biennially from 2001 to 2014. Because this was an observational cohort study, the participants received no intentional interventions, including dietary instructions, except usual medical management for their underlying comorbidities. For the current investigation, subjects with available dietary information from $2 individual surveys were initially screened. After excluding those with missing data or with underlying kidney disease at baseline, a total of 6719 subjects were included in the final analysis. As the mechanisms that contribute to renal dysfunction and phosphorus regulation were expected to differ between DM and non-DM individuals, in addition to the significant interaction between dietary phosphorus density and DM status (P , 0.001), all analyses were performed separately according to the presence of DM (Figure 1 ).
Data collection
A comprehensive health examination was performed, and questionnaires on health and lifestyle were filled out by all participants at the time of study entry. Demographic data, including age, sex, smoking status, alcohol intake, exercise, and medical history, were collected. Subjects with a blood pressure of .140/90 mm Hg or who were taking antihypertensive medications were considered hypertensive. Those who had blood glucose concentrations of $126 mg/dL in .8-h fasting conditions, had postload glucose concentrations of $200 mg/dL after a 75-g oral glucose tolerance test, had glycated hemoglobin $6.5%, or were receiving treatment of hyperglycemia were considered to have DM (13) . Cardiovascular disease was defined as a history of myocardial infarction, coronary artery disease, congestive heart failure, peripheral artery disease, or cerebrovascular disease. Body parameters, including height, body weight, and waist and hip circumferences, were also measured by skilled study workers through standard methods while the subjects were wearing light clothes. The BMI and waist-to-hip ratio were calculated as the weight divided by squared height (kg/m 2 ) and the waist circumference divided by the hip circumference, respectively.
The following biochemical data were determined by using fasting blood samples: concentrations of blood urea nitrogen, creatinine, calcium, phosphorus, glucose, glycated hemoglobin, albumin, total cholesterol, triglyceride, HDL, and C-reactive protein, hemoglobin, and white blood cell count. LDL was FIGURE 1 Flow diagram of the study cohort. eGFR, estimated glomerular filtration rate. calculated by using the formula from Friedewald et al. (14) . Urine samples were collected in the morning after the first voiding. Urinalysis was performed on fresh urine samples by physicians using URISCAN Pro II (YD Diagnostics Corp.). The urine test strip results were based on a color scale that quantified proteinuria as absent, trace, 1+, 2+, or 3+. This scale correlates approximately with urine protein levels of ,10, 10-20, .30, .100, and .500 mg/dL, respectively (15) . The presence of proteinuria was defined as a urinalysis result higher than trace levels. The estimated glomerular filtration rate (eGFR) was calculated by using the CKD epidemiology collaboration equation (16) .
Dietary phosphorus density measurements
Single-day dietary data for the total (in kilocalories), phosphorus (in milligrams), and protein (in grams) intakes were estimated by using a semiquantitative dietary recall food-frequency questionnaire (FFQ), which was conducted twice by trained interviewers. For each participant, the FFQ was conducted at baseline and at 4 y after the initial FFQ. Each FFQ surveyed the type and amount of nutrients consumed over the past year. The average values of FFQs performed at the 4-y interval were used for the analysis. The details of the FFQ have been described, and the validity and reproducibility of the FFQ have been verified previously (17) . The total dietary nutrient and calorie components were calculated by using the 2011 nutrient database of the Korean Nutrition Society. Dietary phosphorus density was defined as the ratio of a single-day dietary phosphorus amount to the total daily calorie intake.
Outcome measures
The primary endpoint was incident CKD, which was defined as a composite of eGFR ,60 mL $ min 21 $ 1.73 m 22 and/or the development of proteinuria during the follow-up period.
Statistical analysis
Statistical analysis was performed by using IBM SPSS software for Windows version 23.0 (IBM Corporation) and R version 3.0.2 (http://cran.r-project.org.). Continuous variables are expressed as means 6 SDs or medians (IQRs), and categorical variables as numbers (percentages). The normality of distribution was ascertained by using the Kolmogorov-Smirnov test. As mentioned above, the patients were first divided into 2 groups according to the presence of DM and were further stratified into quartiles based on the dietary phosphorus density. Stratification was done to include an equal number of individuals in each quartile. The differences among these 4 groups were determined by using ANOVA or the Kruskal-Wallis test for continuous variables and the chi-square test for categorical variables. When statistical significances were found by ANOVA, Tukey's post hoc test was used to assess significant differences across the quartile categories. Dunnett's T3 method was used when the equality of variance assumption was not valid. A linear mixed model was also used to compare the differences among quartiles. For trend analysis, the Jonckheere-Terpstra test and linearby-linear association were used for continuous variables and categorical variables, respectively. Cox proportional hazards regression analysis was performed to determine the independent predictive value of dietary phosphorus density on the development of incident CKD. Further modification of the Cox regression models was made by using a restricted cubic spline model with 2 df to illustrate the systemic relation between dietary phosphorus density and the risk of incident CKD. For all analyses, a P value ,0.05 was considered statistically significant.
RESULTS
Baseline characteristics
The baseline characteristics of the DM and non-DM subjects are shown in Tables 1 and 2, respectively. The mean ages of the subjects were 55.6 6 8.7 and 51.4 6 8.6 y, the numbers of male subjects were 454 (52.0%) and 2784 (47.6%), and the mean concentrations of eGFR were 91.6 6 14.0 and 94.5 6 14.0 mL $ min 21 $ 1.73 m 22 in the DM and non-DM groups, respectively. The mean values of dietary phosphorus density were 0.51 6 0.08 mg/kcal in the DM group and 0.51 6 0.07 mg/kcal in the non-DM group. In the DM group and non-DM group, 4.8% and 7.0% of the participants, respectively, were prescribed with gastritis or ulcer medications.
The absolute amounts of phosphorus intake and dietary protein intake were significantly higher in the highest quartile than in the other quartiles in both the DM and non-DM groups (P , 0.001). In contrast, the waist-to-hip ratio and the proportions of male and low-educated subjects were significantly higher, whereas the serum creatinine and albumin concentrations were significantly lower, in the lowest quartile than in the other quartiles in both groups (P , 0.05 to P , 0.001). There was also a significant difference in the hemoglobin concentrations across the quartiles in both DM (P = 0.015) and non-DM (P , 0.001) groups. In addition, the total calorie intake, systolic and diastolic blood pressures, and serum total cholesterol, triglyceride, HDL cholesterol, and LDL cholesterol concentrations were significantly different among the quartiles in the non-DM group (P , 0.05 to P , 0.001) but not in the DM group. When a linear mixed model was used to confirm the results reported in Tables 1 and 2 , similar findings were observed. In both DM (P , 0.001) and non-DM (P , 0.001) subjects, the dietary phosphorus density significantly differed among quartiles. However, baseline eGFR was comparable among quartiles in both DM (P = 0.845) and non-DM (P = 0.299) groups. A significant interaction was present between DM status and dietary phosphorus density (continuous variables, P , 0.001; quartiles, P , 0.001).
In both DM and non-DM groups, food items with high phosphorus content, such as fast foods and snacks, were consumed more often in quartiles with a higher phosphorus density. However, the intake of soda did not show a significant difference among quartiles (Supplemental Tables 1 and 2).
Development of incident CKD
During a mean follow-up duration of 100.0 6 41.4 mo in the DM group and 115.4 6 33.8 mo in the non-DM group, CKD newly developed in 283 (32.4%) and 792 subjects (13.5%), respectively.
Impact of dietary phosphorus intake on incident CKD
Multivariate Cox proportional hazards regression analysis was performed to clarify the independent predictive power of dietary DIETARY PHOSPHORUS DENSITY AND RENAL OUTCOME phosphorus density on incident CKD and revealed that subjects in the highest quartile in the DM group were at a significantly higher risk of incident CKD development even after adjusting for confounding factors (HR: 1.68; 95% CI: 1.08, 2.63; P = 0.02). In contrast, dietary phosphorus density exerted no significant impact on the development of incident CKD in the non-DM group (HR: 1.04; 95% CI: 0.83, 1.30; P = 0.72) ( Table 3) . A similar finding was found in the survival curves of the DM and non-DM groups (Figure 2) . In the DM group, the trends for HR were significant in models 1 (P = 0.02) and 2 (P = 0.04) but not significant in model 3 (P = 0.06). Meanwhile, no significance was found for HR trends in the non-DM group (model 1, P = 0.25; model 2, P = 0.55; model 3, P = 0.82). Next, the adjusted HRs for incident CKD development according to dietary phosphorus density were described as cubic 21 10.0 6 6.4 10.9 6 6.9 9.9 6 6.5 9.4 6 6.0 9.9 6 6. spline curves. As shown in Figure 3 , there was a gradual increase in the HRs in the DM group when the dietary phosphorus density was higher than 0.45 mg/kcal, although this trend was not found in the non-DM group. The relation between dietary phosphorus density and incident CKD was further explored in subgroups stratified by age, sex, and BMI. The observed effect of phosphorus density on CKD development in the DM group did not differ across subgroups. There were no significant interactions between phosphorus density and subgroup with respect to CKD development in DM patients. (Figure 4 ).
DISCUSSION
In this study, we elucidated the impact of dietary phosphorus density on the development of incident CKD in a prospective cohort of subjects with normal renal function and demonstrated that the dietary phosphorus density was significantly associated with the risk of incident CKD development in subjects with DM even after adjusting for confounding factors.
Data from the third NHANES cohort showed that high dietary phosphorus intake and density were significantly associated with increased mortality in healthy individuals (9) . Moreover, some observational studies have demonstrated a close relation of dietary phosphorus intake with surrogate markers of cardiovascular disease, such as increased left ventricular mass and carotid intima thickness (11, 18) . However, unlike in the case of cardiovascular disease, the impact of dietary phosphorus intake on renal outcomes has not been well evaluated. The results of the current study indicate that dietary phosphorus density is significantly associated with the development of incident CKD in DM individuals with normal renal function, whereas a relation was not found in non-DM subjects. The risk of CKD occurrence significantly increased only in the quartile with the highestphosphorus-density diet after full adjustments were made. Dietary phosphate is not toxic unless very high amounts are consumed. In addition, phosphate is an essential substance for cell survival. Therefore, it is reasonable to presume that increased amounts of phosphorus intake within adequate levels would not cause adverse effects (19) . Nonetheless, it remains unclear whether a clear gradual risk increase would occur for a phosphorus density amount that is above the highest quartile evaluated in the study.
Meanwhile, what are the mechanisms underlying the deleterious effect of high dietary phosphorus density on renal function? Although the impact of dietary phosphorus density on serum phosphate concentrations is not extensive in subjects with normal renal function, the third NHANES study demonstrated that participants allocated to the high-phosphorus-diet group had significantly higher time-averaged serum phosphate concentrations than did the controls (4). Because excessive phosphorus is known to inhibit nitric oxide synthesis in endothelial cells and to induce inflammatory mediators, endothelial dysfunction and inflammation may partly contribute to renal function decline (20) (21) (22) . In addition, when dietary phosphorus intake is increased, fibroblast growth factor-23 (FGF-23) is induced to normalize serum phosphate concentrations. Besides its phosphaturic effect, serum FGF-23 concentrations have been found to associate with CKD progression (23) . Nonetheless, because several nutrients other than phosphorus, such as sodium and potassium, have also been suggested to affect renal function (24, 25) , a confounding effect of these nutrients is possible. Further evaluation while controlling the effects of other nutrients would be needed in future research.
In the present study, dietary phosphorus density was represented as the value of a single-day dietary phosphorus amount standardized by the total daily energy intake. Total calorie intake is frequently associated with disease risk because of the association between physical activity or body size and the likelihood of disease occurrence (26, 27) . Animal and clinical studies have shown that the amount of calorie intake, as well as body size and physical activity, can affect the rate of renal function decline (28) (29) (30) . In addition, intakes of specific nutrients correlate to the amount of total calorie intake, confounding the effect of the nutrient. Moreover, nutrient intake variations resulting from differences in total calorie intake may weaken the relation with disease risk. When adjusting nutrient intake for total calorie intake, nutrient density 
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(nutrient density divided by total calorie) has been used to evaluate the association of diseases in several previous investigations (9, 31) . In this study, phosphorus intake was significantly dependent on total calorie intake (Supplemental Figure 1) . Therefore, phosphorus density was used to evaluate the association with CKD occurrence instead of absolute phosphorus intake. The distribution of phosphorus intake shown in this study is relatively narrow compared with those in previous investigations (9, 11) . In addition, the amount of phosphorus intake in this study individuals. The dark grey lines represent HRs, and shaded areas are 95% CIs. The models were adjusted for age, sex, waist-to-hip ratio, average protein intake, education, income, marital status, smoking status, history of hypertension, eGFR, estimated glomerular filtration rate, fasting glucose, serum albumin, and HDL cholesterol. DM, diabetes mellitus. was also lower than in previous studies (9, 11) . A previous report of the third NHANES showed that the average phosphorus intake of the American population was 1373 mg/d, which is higher than the 959 and 966 mg/d in DM and non-DM individuals, respectively, in the current study. In addition, the average phosphorus density was also higher in Americans, which was reported to be 0.63 mg/kcal (32) , although the results of this study showed a mean value of 0.51 mg/kcal. It is highly probable that this difference is caused by the diversity in dietary culture. The differences in dietary characteristics between Western and Korean cultures have been previously reported. Compared with Korea-born Korean Americans, the intake of fat was higher and sodium was lower in Korean Americans who were born in the United States (33) . In addition, phosphorus intake was reported to be lower in Koreans compared with Americans (34) . Accordingly, the presented results suggest that phosphorus intake is much lower and that the phosphorus density, rather than the absolute phosphorus intake itself, might affect renal function in Asian cultures.
In this study, evaluation was performed separately according to the presence of DM because of the distinct characteristics of renal function decline between DM and non-DM subjects. The risk of CKD development was much higher in DM patients than in non-DM individuals (1). In addition, renal regulation of phosphorus may differ in DM patients. A previous report showed that FGF-23 secretion after phosphorus intake was impaired in DM patients compared with non-DM subjects, suggesting that phosphorus regulatory mechanisms may differ according to DM status (35) . This is supported by the fact that the interaction between phosphorus density and DM was significant. Interestingly, dietary phosphorus density was associated with the risk of incident CKD only in subjects with DM. DM is a typical metabolic disease resulted in endothelial dysfunction and systemic inflammation. As aforementioned, excessive phosphorus is also linked to endothelial dysfunction and inflammation, thus the detrimental consequences of a high dietary phosphorus density on the kidney may be aggravated in DM patients. Furthermore, chronic hypoxia is known to be FIGURE 4 Forest plots for the subgroup analyses of incident chronic kidney disease development according to dietary phosphorus density in DM and non-DM individuals. All models were adjusted for age, sex, waist-to-hip ratio, average protein intake, education, income, marital status, smoking status, history of hypertension, estimated glomerular filtration rate, fasting glucose, serum albumin, and HDL cholesterol. DM, diabetes mellitus; Q, quartile.
induced in high-oxygen-consuming cells, such as renal tubular cells, under DM conditions (36) . Recently, phosphorus-induced vascular smooth muscle cell calcification was shown to be synergized under hypoxic conditions by activating hypoxiainducible factor-1 (37) . Taken together, a high dietary phosphorus density may further aggravate renal injury in DM subjects, partly mediated by DM-induced cellular hypoxia.
There are a number of limitations in this study. First, the precise assessment of dietary intake in a large-sized cohort is challenging. Because the dietary intake was ascertained by an FFQ, the dietary intake data may be inaccurate. Nevertheless, the validity and reproducibility of the FFQ used in the current study have been previously verified (17) , supporting the reliability of the dietary data used in our investigation. In addition, the amount of phosphorus intake for each individual would have varied throughout the study period. Therefore, to describe the amount of phosphorus intake as closely as possible to the actual consumed amount over the years, the average value of FFQs performed at a 4-y interval was used for analysis. Second, the serum phosphate and FGF-23 concentrations were not available. Therefore, the correlations between dietary phosphorus density and these variables could not be estimated. However, based on the results of previous large-scale epidemiology studies on subjects with normal renal function (10, 11) , high dietary phosphorus intake is presumed to increase the serum FGF-23 concentrations, although it was impossible to examine in our study. Third, the exact sources of dietary phosphorus could not be determined. The main food items through which Koreans ingest phosphorus are cooked rice (246.9 mg/d), milk (71.2 mg/d), pork (50.2 mg/d), eggs (41.6 mg/d), and kimchi (Korean cabbage, 39.8 mg/d). These items are known to be consumed predominantly by ordinary agriculture products than by food preservatives and account for w40% of the average daily phosphorus intake (38) . The KoGES cohort used in this study does not distinguish organic sources of phosphorus from inorganic sources. However, although a clear distinction between these 2 phosphorus sources was difficult to make, information of specific food types was provided to offer a better estimation of the phosphorus source.
In conclusion, a high dietary phosphorus density may increase the risk of incident CKD in DM patients with preserved renal function. Further investigations are needed to evaluate the effect of lowering the dietary phosphorus density through diet modifications on the renal outcomes in these patients.
